Why is QMS Medical falling/rising?

As of 30-Jun, QMS Medical Allied Services Ltd is experiencing a decline in its stock price, currently at 82.70, reflecting a decrease of 1.85 or 2.19%. The stock has underperformed its sector today by 5.58%, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has seen a return of -7.08%, and for the month, it has declined by 6.71%. Despite this downturn, there has been a notable increase in investor participation, with delivery volume rising by 140.74% compared to the 5-day average. The company has reported positive financial results for March 25, including the highest quarterly net sales and operating profit margins, which suggests a strong operational performance despite the stock's poor price movement.
In the broader market context, the Sensex has shown resilience, gaining 2.18% over the past week and 3.10% over the past month, contrasting sharply with QMS Medical's performance. This divergence indicates that while the overall market is trending positively, QMS Medical is struggling significantly, with a year-to-date decline of 27.10% compared to the Sensex's increase of 7.92%. The company's attractive valuation metrics, such as a PEG ratio of 0.9 and a return on capital employed of 13.1, suggest that it may be undervalued relative to its peers, yet this has not translated into positive stock performance, highlighting a disconnect between market perception and the company's financial health.